AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis

被引：0
|
作者：
Mullen, M. M. [1 ]
Quinn, J. M. [1 ]
Greenwade, M. [2 ]
Opara, G. [1 ]
Beck-Noia, H. [1 ]
Hagemann, I. S. [1 ]
Hagemann, A. R. [1 ]
Kuroki, L. M. [1 ]
McCourt, C. K. [3 ]
Thaker, P. H. [1 ]
Powell, M. A. [1 ]
Mutch, D. G. [1 ]
Fuh, K. C. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1257
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [1] Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma
    Kang, Kyong-Won
    Lee, Mi-Jung
    Song, Ji-Ae
    Jeong, Ju-Yeon
    Kim, Yoo-Kyong
    Lee, Chan
    Kim, Tae-Heon
    Kwak, Kyu-Beom
    Kim, Ok-Jun
    An, Hee Jung
    ONCOLOGY REPORTS, 2014, 32 (01) : 189 - 198
  • [2] Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
    Choi, Chel Hun
    Kang, Tae Heung
    Song, Joon Seon
    Kim, Young Seob
    Chung, Eun Joo
    Ylaya, Kris
    Kim, Seokho
    Koh, Sang Seok
    Chung, Joon-Yong
    Kim, Jae-Hoon
    Hewitt, Stephen M.
    SCIENTIFIC REPORTS, 2018, 8
  • [3] Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
    Chel Hun Choi
    Tae Heung Kang
    Joon Seon Song
    Young Seob Kim
    Eun Joo Chung
    Kris Ylaya
    Seokho Kim
    Sang Seok Koh
    Joon-Yong Chung
    Jae-Hoon Kim
    Stephen M. Hewitt
    Scientific Reports, 8
  • [4] High Axl expression is associated with markers of poor prognosis in African breast cancer
    Ahmed, L.
    Nalwoga, H.
    Micklem, D. R.
    Arnes, J. B.
    Wabinga, H.
    Akslen, L. A.
    VIRCHOWS ARCHIV, 2014, 465 : S108 - S109
  • [5] Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer
    Song, Jiandong
    Yang, Pengxia
    Lu, Jianjun
    CANCER BIOMARKERS, 2020, 27 (01) : 51 - 61
  • [6] Overexpression of \#945;PIX contributes to ovarian cancer metastasis, increased chemoresistance and poor prognosis
    Kong, Daniel
    Siu, Michelle
    Chan, Hoi Yan
    Jiang, Li Li
    Tam, Kar Fai
    Chan, Queeny
    Ngan, Hextan
    Le, Lawrence
    Cheung, Annie
    CANCER RESEARCH, 2009, 69
  • [7] Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance
    Yamamoto, Sohei
    Tsuda, Hitoshi
    Honda, Kazufumi
    Onozato, Kaoru
    Takano, Masashi
    Tamai, Seiichi
    Imoto, Issei
    Inazawa, Johji
    Yamada, Tesshi
    Matsubara, Osamu
    MODERN PATHOLOGY, 2009, 22 (04) : 499 - 507
  • [8] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
    Itamochi, Hiroaki
    Kigawa, Junzo
    Terakawa, Naoki
    CANCER SCIENCE, 2008, 99 (04) : 653 - 658
  • [9] Synchronous Diagnosis of Metastatic Cancer to the Thyroid is Associated with Poor Prognosis
    Jeng-Yeou Chen
    I-Wen Chen
    Chuen Hsueh
    Tzu-Chieh Chao
    Bing-Ru Gao
    Jen-Der Lin
    Endocrine Pathology, 2015, 26 : 80 - 86
  • [10] Overexpression of salusin-β is associated with poor prognosis in ovarian cancer
    Zhang, Qian
    Chen, Wen-Ming
    Zhang, Xin-Xin
    Zhang, Hu-Xiang
    Wang, Han-Chu
    Zheng, Fei-Yun
    Zhu, Fang-Fang
    ONCOLOGY REPORTS, 2017, 37 (03) : 1826 - 1832
12345